Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OmniAb, Inc. - Common Stock (NQ: OABI )

4.430 -0.130 (-2.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 586,988
Open 4.520
Bid (Size) 4.390 (2)
Ask (Size) 4.990 (1)
Prev. Close 4.560
Today's Range 4.410 - 4.520
52wk Range 3.140 - 6.715
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OmniAb to Report First Quarter 2024 Financial Results on May 9
From OmniAb, Inc.
Via Business Wire
Over $1M Bet On OmniAb? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Monday, there were a few notable insider trades. 
Via Benzinga

Performance

YTD
-29.12%
-29.12%
1 Month
-14.64%
-14.64%
3 Month
-27.02%
-27.02%
6 Month
-0.89%
-0.89%
1 Year
+26.57%
+26.57%

More News

Read More
OABI Stock Earnings: OmniAb Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Recap: OmniAb Q4 Earnings
Via Benzinga
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
Earnings Preview For OmniAb
Via Benzinga
Earnings Scheduled For March 20, 2024
Via Benzinga
OmniAb to Report Fourth Quarter 2023 Financial Results on March 20
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in Two Investor Conferences in March
From OmniAb, Inc.
Via Business Wire
Mighty Minis: 7 Small-Cap Stocks That Punch Above Their Weight
Via InvestorPlace
OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference
From OmniAb, Inc.
Via Business Wire
OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual Event
From OmniAb, Inc.
Via Business Wire
OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
OmniAb to Participate in Two Investor Conferences in November
From OmniAb, Inc.
Via Business Wire
OmniAb Appoints Steve Love to its Board of Directors
From OmniAb, Inc.
Via Business Wire
OmniAb Announces Agenda for its Research & Technology Virtual Event
From OmniAb, Inc.
Via Business Wire
7 of the Best Cheap Stocks to Buy Under $5 in October 2023
Via InvestorPlace
OmniAb to Hold Research & Technology Virtual Event on November 9
From OmniAb, Inc.
Via Business Wire
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
OmniAb to Participate in Two Investor Conferences in September
From OmniAb, Inc.
Via Business Wire
OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights
From OmniAb, Inc.
Via Business Wire
OmniAb Announces the Passing of Director Sunil Patel
From OmniAb, Inc.
Via Business Wire
OmniAb to Report Second Quarter 2023 Financial Results on August 10
From OmniAb, Inc.
Via Business Wire
7 Stocks to Buy for 200% Returns This Year
Via InvestorPlace
Earnings Scheduled For August 10, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.